[1] Xu M. Research on main mechanisms of MIRI and related drug therapy [J]. Practical Pharmacy and Clinical Remedies,2014,17 (8):1052-1056.(in Chinese)
徐盟. 心肌缺血再灌注损伤的主要机制与相关药物治疗的研究进展 [J]. 实用药物与临床,2014,17 (8):1052-1056.
[2] Raedschelders K,Ansley DM,Chen DD. The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion [J]. Pharmacol Ther, 2012,133 (2):230-255.
[3] Yin Z,Pascual C,Klionsky D. Autophagy:machinery and regulation [J]. Microbial Cell, 2016,3 (12): 588-596.
[4] Ma S,Wang Y,Chen Y,et al. The role of the autophagy in myocardial ischemia/reperfusion injury [J]. BBA-Biomembranes,2015,1852 (2): 271-276.
[5] Wu Y,He L. Advances in research on mechanisms of myocardial ischemia-reperfusion injury and related therapeutic drugs [J]. Progress in Pharmaceutical Sciences,2010,34 (7):305-312.(in Chinese)
吴烨,何玲. 心肌缺血再灌注损伤的机制研究进展及相关药物的研发 [J]. 药学进展,2010,34 (7):305-312.
[6] Chen ChJ,Pan X,Zhao MJ,et al. Establishment and assessment of a Langendroff perfused rat heart model of ischemia- reperfusion [J]. Chinese Journal of Comparative Medicine,2013,23 (12): 21-26.(in Chinese)
陈婵娟,潘昡,赵明镜, 等. 大鼠Langendroff离体心脏局部缺血再灌注模型建立及功能评价[J]. 中国比较医学杂志,2013,23 (12):21-26.
[7] Ferrera R,Benhabbouche S,Bopassa JC,et al. One hour reperfusion is enough to assess function and infarct size with TTC staining in Langendorff rat model [J]. Cardiovasc Drugs Ther,2009,23 (4):327-331.
[8] Ferdinandy P,Schulz R,Baxter GF. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury,preconditioning and postconditioning [J]. Pharmacol Rev,2007,59 (4): 418-458.
[9] Fang H,Zhang Y,Li J,et al. Protective effects of total flavones from Salix caprea flowers against myocardial ischemia-reperfusion injury in rats [J]. Chinese Journal of New Drugs,2016 (8): 949-953.(in Chinese)
方贺,张雅,李佳, 等. 黄花柳花总黄酮对心肌缺血再灌注损伤的保护作用机制[J]. 中国新药杂志,2016 (8):949-953.
[10] Yang QY,Kang L,Gu ShY,et al. Pharmacokinetics studies of ginsenoside Rb1 in rats [J]. Chinese Pharmaceutical Journal,2014,49 (3): 221-226.(in Chinese)
杨秋娅,康雷,顾圣莹, 等. 人参皂苷Rb1在大鼠体内的药动学研究[J]. 中国药学杂志,2014,49 (3):221-226.
[11] Yang JY,Zhang YCh,Tang JM,et al. Correlation between cardiac function changes and myocardial infarct size after myocardial ischemia-reperfusion in rat [J]. Laboratory Animal and Comparative Medicine,2008,28 (1): 4-9.(in Chinese)
杨建业,张迎春,唐俊明, 等. 大鼠心肌缺血再灌注后心功能变化与心肌梗死面积的相关性分析 [J]. 实验动物与比较医学,2008,28 (1): 4-9.
[12] Matsui Y,Takagi H,Qu X,et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy [J]. Circ Res,2007,100 (6): 914.
[13] Ma S,Wang Y,Chen Y,et al. The role of the autophagy in myocardial ischemia/reperfusion injury [J]. BBA-Mol Basis Dis,2015,1852 (2):271-276.
[14] Shen XZh,Wang L,Fang YH. Artemisinin alleviates myocardial ischemia and reperfusion injury via autophagy regulation [J]. Anhui Medical and Pharmaceutical Journal,2016,20 (6): 1065-1067.(in Chinese)
沈秀珍,王凌,方毅华. 银杏总黄酮通过调节自噬减轻大鼠心肌缺血再灌注损伤的研究[J]. 安徽医药,2016,20 (6):1065-1067.
[15] Shen JJ,Huang Y,Qi WG,et al. Resveratrol reduces cardiac ischemia-reperfusion injury of diabetic rats by promoting autophagy in experimental study [J]. Chinese Journal of Clinical Medicines,2015 (2):151-155.(in Chinese)
沈佳佳,黄瑛,祁炜罡, 等. 白藜芦醇通过促进自噬减轻糖尿病大鼠心肌缺血再灌注损伤的实验研究 [J]. 中国临床医学,2015 (2):151-155.
[16] Wang PB,Wang GG. The role of autophagy in heart failure-from autophagosome to autophagy flux [J]. Advances in cardiovascular Diseases,2014,35 (4):419-422.(in Chinese)
王鹏博,王国干. 自噬在心力衰竭中的利弊评价——从自噬体到自噬流 [J]. 心血管病学进展,2014,35 (4):419-422.
[17] Messer JS. The cellular autophagy/apoptosis checkpoint during inflammation [J]. Cell Mol Life Sci,2016,74 (7):1-16.
[18] Yin Z,Pascual C,Klionsky DJ. Autophagy:machinery and regulation [J]. Microb Cell Fact,2016,3 (12):588-596.
[19] Wei YM. Effects of various autophagy modulators on the expression of autophagic markers LC3Ⅱ and p62 [J]. Journal of China Pharmaceutical University,2018,49 (3):341-347.(in Chinese)
魏砚明. 多种细胞自噬调节剂对自噬标记物LC3II及p62表达的影响 [J]. 中国药科大学学报,2018,49 (3):341-347.
|